BRKR Quote, Financials, Valuation and Earnings

Technicals

Company Profile

Bruker Corp. engages in the business of developing, manufacturing, and distributing high-performance scientific instruments and analytical and diagnostic solutions that enable customers to explore life and materials at microscopic, molecular, and cellular levels. It operates through the following segments: Bruker Scientific Instruments (BSI) BioSpin, BSI Chemicals, Applied Markets, Life Science, In-Vitro Diagnostics, Detection (CALID), BSI Nano, and Bruker Energy and Supercon Technologies (BEST). The BSI BioSpin segment includes life science tools based on magnetic resonance technology. The BSI CALID segment focuses on life science mass spectrometry and ion mobility spectrometry solutions, analytical and process analysis instruments, and solutions based on infrared and Raman molecular spectroscopy technologies and radiological and nuclear detectors for chemical, biological, radiological, nuclear, and explosive detection. The BSI Nano segment offers advanced x-ray instruments, atomic force microscopy instrumentation, advanced fluorescence optical microscopy instruments, analytical tools for electron microscopes and x-ray metrology, defect-detection equipment for semiconductor process control, handheld, portable, and mobile x-ray fluorescence spectrometry instruments, spark optical emission spectroscopy systems, and chip cytometry products and services for targeted spatial proteomics, multi-omics services, and products and services for spatial genomics research. The BEST segment is involved in superconducting and non-superconducting materials and devices for use in renewable energy, energy infrastructure, healthcare, and big science research. The company was founded by Emil Bruker and Günther Laukien in 1960 and is headquartered in Billerica, MA.

Stock Forecast FAQ

In the current month, BRKR has received 7 Buy ratings 5 Hold ratings, and 1 Sell ratings. The BRKR average analyst price target in the past 3 months is $51.79.

• Where Will Bruker Corp. Stock Be In 1 Year?

  According to analysts, the consensus estimate is that Bruker Corp. share price will rise to $51.79 per share over the next 12 months.

• What Do Analysts Say About Bruker Corp.?

  Analysts are divided on their view about Bruker Corp. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Bruker Corp. is a Sell and believe this share price will drop from its current level to $40.00.

• What Is Bruker Corp.'s Price Target?

  The price target for Bruker Corp. over the next 1-year time period is forecast to be $51.79 according to 13 Wall Street analysts, 7 of them rate the stock a Buy, 1 rates the stock a Sell, and 5 analysts rate the stock a Hold.

• Is BRKR A Buy, Sell Or Hold?

  According to Wall Street analysts, the consensus rating for Bruker Corp. is a Buy. 7 of 13 analysts rate the stock a Buy at this time.

• How Can I Buy Shares Of BRKR?

  You can purchase shares of Bruker Corp. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Bruker Corp. shares.

• What Is The Bruker Corp. Share Price Today?

  Bruker Corp. was last trading at $48.13 per share. This represents the most recent stock quote for Bruker Corp.. Yesterday, Bruker Corp. closed at $48.12 per share.

• How To Buy Bruker Corp. Stock Online?

  In order to purchase Bruker Corp. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.

Related Companies

• Agilent Technologies, Inc.
• Avantor, Inc.
• Azenta, Inc.
• Harvard Bioscience, Inc.
• Revvity, Inc.